NDC properties for "tetracycline hydrochloride 250 MG Oral Capsule" (RxCUI 198250)
About this data
The tables show NDC propoerties for tetracycline hydrochloride 250 MG Oral Capsule with the RxCUI 198250
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for tetracycline hydrochloride 250 MG Oral Capsule (RxCUI 198250)
| ANDA | ANDA060704 |
|---|---|
| ANDA | ANDA061837 |
| ANDA | ANDA062752 |
| ANDA | ANDA210662 |
| ANDA | ANDA210674 |
| ANDA | ANDA212635 |
| MMSL_CODE | BD3024 |
| NDA | NDA050278 |
| RxCUI | 198250 |
| SNOMEDCT | 374237001 |
| SPL_SET_ID | 00acf413-c5d2-4a54-9d0d-56266cbc9edc |
| SPL_SET_ID | 2854d3b7-f874-4c67-8014-adda9639f515 |
| SPL_SET_ID | 32a409a0-fea6-411a-8218-c1c7df46d664 |
| SPL_SET_ID | 3ce3e8dc-7fbd-4f8d-a65f-092e1ef21725 |
| SPL_SET_ID | 5419f5dd-bf20-4eea-982d-33511a022c38 |
| SPL_SET_ID | 58e4b5b3-e093-46e7-b28e-a2c4821c5b63 |
| SPL_SET_ID | 6f363d06-2400-43be-8fe5-69246c0fdc49 |
| SPL_SET_ID | aa30113f-ab58-4f41-82c1-2fcb540d4a82 |
| SPL_SET_ID | ae29aa18-6efb-47c9-bbd7-cbe8af1b7f38 |
| SPL_SET_ID | b45cee2a-8d11-4fda-b8f8-e1f71abf87c6 |
| SPL_SET_ID | b504e612-5aef-47fa-8f7b-dfb754011b9f |
| SPL_SET_ID | eaa5b1bd-0927-46e4-b941-32fcc492d258 |
| SPL_SET_ID | fb338af1-2b1b-413f-9653-10f318dbc4b3 |
| VUID | 4001908 |
| Prescribable Synonym | tetracycline HCl 250 MG Oral Capsule |
| RXNAV_STR | tetracycline hydrochloride 250 MG Oral Capsule |
| RxNorm Name | tetracycline hydrochloride 250 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 198250) |
NDC Properties
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 00440250528
| NDC 9 | 0440-2505 |
|---|---|
| NDC 10 | 0440-2505-28 |
| NDC Item | 00440250528 |
| Related queries | Properties for NDC 9 0440-2505 |
NDC Item 00591247401
| NDC 9 | 0591-2474 |
|---|---|
| NDC 10 | 0591-2474-01 |
| NDC Item | 00591247401 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2474-01) |
| ANDA | ANDA061837 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2234 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 0591-2474 |
NDC Item 00917080901
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00917080901 |
| Related queries | Properties for NDC 9 |
NDC Item 23155001701
| NDC 9 | 23155-017 |
|---|---|
| NDC 10 | 23155-017-01 |
| NDC Item | 23155001701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-017-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;17 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 23155-017 |
NDC Item 23155076601
| NDC 9 | 23155-766 |
|---|---|
| NDC 10 | 23155-766-01 |
| NDC Item | 23155076601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-766-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow(Yellow Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5225 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 23155-766 |
NDC Item 47781050801
| NDC 9 | 47781-508 |
|---|---|
| NDC 10 | 47781-508-01 |
| NDC Item | 47781050801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-508-01) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48330;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5225 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-07-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-508 |
NDC Item 51991090601
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-01 |
| NDC Item | 51991090601 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090605
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-05 |
| NDC Item | 51991090605 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 51991090633
| NDC 9 | 51991-906 |
|---|---|
| NDC 10 | 51991-906-33 |
| NDC Item | 51991090633 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-906-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 777555 |
| Imprint code | B906 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 51991-906 |
NDC Item 52959028300
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-00 |
| NDC Item | 52959028300 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028312
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-12 |
| NDC Item | 52959028312 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028320
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-20 |
| NDC Item | 52959028320 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028328
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-28 |
| NDC Item | 52959028328 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028330
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-30 |
| NDC Item | 52959028330 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 52959028340
| NDC 9 | 52959-283 |
|---|---|
| NDC 10 | 52959-283-40 |
| NDC Item | 52959028340 |
| Related queries | Properties for NDC 9 52959-283 |
NDC Item 60219152201
| NDC 9 | 60219-1522 |
|---|---|
| NDC 10 | 60219-1522-1 |
| NDC Item | 60219152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 60219-1522 |
NDC Item 62135022501
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-01 |
| NDC Item | 62135022501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-225-01) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022505
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-05 |
| NDC Item | 62135022505 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-225-05) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022520
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-20 |
| NDC Item | 62135022520 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-225-20) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 62135022560
| NDC 9 | 62135-225 |
|---|---|
| NDC 10 | 62135-225-60 |
| NDC Item | 62135022560 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-225-60) |
| ANDA | ANDA062752 |
| COLORTEXT | yellow |
| Color | C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5225 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 62135-225 |
NDC Item 64380089006
| NDC 9 | 64380-890 |
|---|---|
| NDC 10 | 64380-890-06 |
| NDC Item | 64380089006 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-890-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;01 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 64380-890 |
NDC Item 66267020012
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-12 |
| NDC Item | 66267020012 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020028
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-28 |
| NDC Item | 66267020028 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 66267020040
| NDC 9 | 66267-200 |
|---|---|
| NDC 10 | 66267-200-40 |
| NDC Item | 66267020040 |
| Related queries | Properties for NDC 9 66267-200 |
NDC Item 67405066010
| NDC 9 | 67405-660 |
|---|---|
| NDC 10 | 67405-660-10 |
| NDC Item | 67405066010 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-660-10) |
| ANDA | ANDA062752 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5225 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-02-28 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 67405-660 |
NDC Item 69238152201
| NDC 9 | 69238-1522 |
|---|---|
| NDC 10 | 69238-1522-1 |
| NDC Item | 69238152201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1522-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1522 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 69238-1522 |
NDC Item 71335241501
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-1 |
| NDC Item | 71335241501 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2415-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241502
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-2 |
| NDC Item | 71335241502 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2415-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241503
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-3 |
| NDC Item | 71335241503 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2415-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241504
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-4 |
| NDC Item | 71335241504 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2415-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241505
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-5 |
| NDC Item | 71335241505 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2415-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241506
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-6 |
| NDC Item | 71335241506 |
| Packaging | 112 CAPSULE in 1 BOTTLE (71335-2415-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241507
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-7 |
| NDC Item | 71335241507 |
| Packaging | 6 CAPSULE in 1 BOTTLE (71335-2415-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |
NDC Item 71335241508
| NDC 9 | 71335-2415 |
|---|---|
| NDC 10 | 71335-2415-8 |
| NDC Item | 71335241508 |
| Packaging | 10 CAPSULE in 1 BOTTLE (71335-2415-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE,YELLOW |
| Color | C48333;C48330 __ |
| FDA SPL set id | 829878 |
| Imprint code | B906 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 71335-2415 |